|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio. |
| 公司地址
| 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400 |
| 電話號碼
| +1 847 932-7900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.abbvie.com |
| 員工數量
| 57000 |
| Mr. David R. Purdue |
Principal Accounting Officer, Senior Vice President and Controller |
-- |
20/02/2026 |
| Mr. Demetris D. Crum |
Executive Vice President and Chief Human Resources Officer |
-- |
20/02/2026 |
| Dr. Roopal Thakkar, M.D. |
Executive Vice President, Research and Development and Chief Scientific Officer |
-- |
20/02/2026 |
| Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD |
Executive Vice President and Chief Operations Officer |
美元 1.02M |
20/02/2026 |
| Dr. Nicholas J. Donoghoe, M.D. |
Executive Vice President, Chief Business and Strategy Officer |
-- |
20/02/2026 |
| Mr. Robert A. Michael |
Chairman of the Board and Chief Executive Officer |
美元 1.61M |
20/02/2026 |
| Mr. Jeffrey Ryan Stewart |
Executive Vice President and Chief Commercial Officer |
美元 1.28M |
20/02/2026 |
| Mr. Scott T. Reents |
Executive Vice President and Chief Financial Officer |
美元 1.07M |
20/02/2026 |
| Mr. Perry C. Siatis |
Executive Vice President, General Counsel and Secretary |
-- |
20/02/2026 |
|
|
| Mr. Frederick H. Waddell |
Independent Director |
20/02/2026 |
| Ms. Rebecca B. Roberts |
Independent Director |
20/02/2026 |
| Dr. Robert J. Alpern,M.D. |
Independent Director |
20/02/2026 |
| Mr. Thomas C. Freyman |
Independent Director |
20/02/2026 |
| Mr. Edward J. Rapp |
Independent Director |
20/02/2026 |
| Dr. Susan E. Quaggin, M.D. |
Independent Director |
20/02/2026 |
| Ms. Roxanne S. Austin |
Lead Independent Director |
20/02/2026 |
| Mr. Brett J. Hart |
Independent Director |
20/02/2026 |
| Mr. William H.L. Burnside |
Independent Director |
20/02/2026 |
| Ms. Melody B. Meyer |
Independent Director |
20/02/2026 |
| Mr. Robert A. Michael |
Chairman of the Board and Chief Executive Officer |
20/02/2026 |
| Mr. Thomas J. Falk |
Independent Director |
20/02/2026 |
| Ms. Jennifer L. Davis |
Independent Director |
20/02/2026 |
|
|
|
|
